Клиническое применение протонной радиотерапии при лечении опухолевых заболеваний
- Авторы: Кубеш Й.1
-
Учреждения:
- OOO «Онкологический центр протонной терапии»
- Выпуск: Том 19, № 5 (2014)
- Страницы: 4-10
- Раздел: Статьи
- URL: https://bakhtiniada.ru/1028-9984/article/view/40069
- DOI: https://doi.org/10.17816/onco40069
- ID: 40069
Цитировать
Полный текст
Аннотация
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
Йиржи Кубеш
OOO «Онкологический центр протонной терапии»
Email: info@ptc.cz
д-р наук, зав. отд. протонной терапии ООО «Онкологический центр протонной терапии», зам. председателя Чешского общества радиационной онкологии, биологии и физики 18000, г. Прага, Чешская Республика
Список литературы
- Amichetti M., Amelio D., Cianchetti M. A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base. Neurosurg. Rev. 2010; 33: 155-65.
- Johansson S., Astrom L., Sandin F. et al. Hypofractionated proton boostcombined with external beam radiotherapy for treatment of localized prostate cancer. Prostate Cancer. 2012: 2012; article ID 654861.
- Hoppe B.S., Flampouri S. et al. Consolidative involved-node proton therapy for stage IA-IIIB mediastinal hodgkin lymphoma: Preliminary dosimetric outcomes from a phase II study. Int. J. Radiat. Oncol. Biol. Phys. 2012; 83: 260-7.
- Hoppe B.S., Nichols R.C., Henderson R.H. et al. Erectile function, incontinence,and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer. 2012; 118: 4619-26.
- Ludkvist J., Ekman M., Rehn Ericsson S. et al. Cost-effectiveness of proton radiation in the treatment of childhood edulloblastoma. Cancer. 2005; 103: 793-801.
- Mahadevan A., Miksad R., Goldstein M. et al. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81: 615-22.
- Marucci L., Ancukiewicz M., Lane A.M. et al. Uveal melanoma recurrence after fractioned proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int. J. Radiat. Oncol. Biol. Phys. 2011; 79: 842-6.
- Merchant T.E. Proton beam therapy in pediatric onkolo. Cancer J. 2009; 15(4): 298-305.
- Mosci C., Lanza F.B., Barla A. et al. Uveal melanoma recurrence after fractioned proton beam therapy: comparison of survival in patients reated with enucleation or proton beam radiotherapy. Ophthalmologica. 2012; 227: 190-6.
- Nakayama H., Sugahara S., Tokita M. et al. Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the University of Tsukuba. Int. J. Radiat. Oncol. Biol. Phys. 2010; 78: 467-71.
- Nihei K., Ogino T., Onozawa M. et al. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81: 390-6.
- Sejpal S., Komaki R., Tsao A. et al. Early findings on toxicity of protonbeam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer. 2011; 117: 3004-13.
- Slater J.D., Yonemoto L.T., Mantik D.W. et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int. J. Radiat. Oncol. Biol. Phys. 2005; 62: 494-500.
- Terashima K., Demizu Y., Hashimoto N. et al. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother. Oncol. 2012; 103: 25-31.
- Truong M.T., Kamat U.R., Liebsch N.J. et al. Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors. Head Neck. 2009; 31: 1297-308.
- Wang Z., Nabhan M., Schild S.E. et al. Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 2013; 86: 18.
- Westover K.D., Seco J., Adams J. A. et al. Proton SBRT for medically inoperable stage I NSCLC. Thorac. Oncol. 2012; 7: 1021-5.
- Xiang Z.L., Erasmus J., Komaki R. et al. FDG uptake correlates with recurrenceand survival after treatment of unresectable stage III on-small cell lung cancer with high-dose proton therapy and chemotherapy. Radiat. Oncol. 2012; 28: 144.
- Zenda S., Kohno R., Kawashima M. et al. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81: 1473-8.
- Zietman A.L., Desilvio M.L., Slater J.D. Comparison of conventional-dose vshigh-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. J.A.M.A. 2005; 294: 1233-9.
Дополнительные файлы
